Matthew Bieniosek

Matthew Bieniosek

Auto-generated profile, based on publicly available information

Matthew Bieniosek

Enable Medicine, Menlo Park, CA, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2025 in Nature Communications
Verified
Journal Article
Open access
EWEric Wu
Eric Wu
MBMatthew Bieniosek
Matthew Bieniosek
ZWZhenqin Wu
Zhenqin Wu
NTNitya Thakkar
Nitya Thakkar
GCGregory Charville
Gregory Charville
JZJames Y Zou
James Y Zou
Hematoxylin and eosin (H&E) is a common and inexpensive histopathology assay. Though widely used and information-rich, it cannot directly inform about specific molecular markers, which require additional experiments to assess. To address this gap, we present ROSIE, a deep-learning framework that computationally imputes the expression and localization of dozens of proteins from H&E images. Our model is trained on a dataset of over 1300 paired and aligned H&E and multiplex immunofluorescence (mIF) samples from over a dozen tissues and disease conditions, spanning over 16 million cells. Validation of our in silico mIF staining method on held-out H&E samples demonstrates that the predicted biomarkers are effective in identifying cell phenotypes, particularly distinguishing lymphocytes such as B cells and T cells, which are not readily discernible with H&E staining alone. Additionally, ROSIE facilitates the robust identification of stromal and epithelial microenvironments and immune cell subtypes like tumor-infiltrating lymphocytes (TILs), which are important for understanding tumor-immune interactions and can help inform treatment strategies in cancer research.